NEOGENOMICS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $727.3 | $660.6 | $591.6 | $509.7 | $484.3 |
| Operating income | -$115.9 | -$92.1 | -$107.7 | -$157.6 | -$118.8 |
| Net income | -$108.0 | -$78.7 | -$88.0 | -$144.2 | -$8.3 |
| Balance Sheet | |||||
| Total debt | $345.0 | $546.2 | $538.2 | $535.4 | $533.7 |
| Cash Flow Statement | |||||
| Free cash flow | -$21.8 | -$34.0 | -$30.7 | -$96.9 | -$90.9 |
Shares outstanding 128.5M · Free float 95.9%
Annual filing data through FY ended December 31, 2025; float as of October 10, 2026.